Insmed | INSM - Current Assets

Stock Price
156.24
Daily Change
-2.79 -1.75%
Monthly
-2.18%
Yearly
101.60%
Q1 Forecast
159.80

Insmed reported $1.79B in Current Assets for its fiscal quarter ending in December of 2025.





Current Assets Change Date
BioMarin Pharmaceutical USD 3.95B 98.95M Dec/2025
Cytokinetics USD 977.35M 90.81M Sep/2025
DBV Technologies USD 88.88M 32.36M Sep/2025
Gilead Sciences USD 19.89B 1.05B Dec/2025
Heron Therapeutics USD 229.4M 18.48M Sep/2025
Insmed USD 1.79B 137.6M Dec/2025
Novartis USD 28.2B 2.26B Sep/2025
Regeneron Pharmaceuticals USD 18.02B 41.2M Dec/2025
Sarepta Therapeutics USD 2.72B 65.32M Sep/2025
Ultragenyx Pharmaceutical USD 643.21M 76.58M Sep/2025
Vertex Pharmaceuticals USD 11.2B 631.4M Dec/2025